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Abstract
Background
Early detection and diagnosis of tuberculosis remain major global priorities for tuberculosis
control. Few studies have used a qualitative approach to investigate the social determinants
contributing to diagnostic delay and none have compared data collected from individual,
community, and health-system levels. We aimed to characterize the social determinants
that contribute to diagnostic delay among persons diagnosed with tuberculosis living in
resource-constrained settings.
Methods/Principle findings
Data were collected in public health facilities with high tuberculosis incidence in 19 districts
of Lima, Peru. Semi-structured interviews with persons diagnosed with tuberculosis (n = 105)
and their family members (n = 63) explored health-seeking behaviours, community percep-
tions of tuberculosis and socio-demographic circumstances. Focus groups (n = 6) were con-
ducted with health personnel (n = 35) working in the National Tuberculosis Program. All
interview data were transcribed and analysed using a grounded theory approach. The
median delay between symptom onset and the public health facility visit that led to the first
positive diagnostic sample was 57 days (interquartile range 28–126). The great majority of
persons diagnosed with tuberculosis distrusted the public health system and sought care at
public health facilities only after exhausting other options. It was universally agreed that per-
sons diagnosed with tuberculosis faced discrimination by public and health personnel. Self-
medication with medicines bought at local pharmacies was reported as the most common
initial health-seeking behaviour due to the speed and low-cost of treatment in pharmacies.
Most persons diagnosed with tuberculosis initially perceived their illness as a simple virus.
Conclusions
Diagnostic delay was common and prolonged. When individuals reached a threshold of
symptom severity, they addressed their health with the least time-consuming, most
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economically feasible, and well-known healthcare option available to them. In high-burden
settings, more human and material resources are required to promote tuberculosis case-
finding initiatives, reduce tuberculosis associated stigma and address the social determi-
nants underlying diagnostic delay.
Introduction
Although effective treatment has existed for more than 50 years, tuberculosis (TB) is the most
frequent infectious cause of death worldwide [1]. An estimated 10.4 million people developed
TB disease in 2015 –the majority of cases occurring in low- and middle-income countries such
as Peru [1]. Although Peru has a model National TB Program (NTP) that incorporates directly
observed therapy (DOT) and provides medications, diagnostic tests, and psycho-social services
free of direct charges, it continues to have the second highest TB burden in the Americas. In
2015, the estimated incidence rate was 119 per 100,000 population [2]. The incidence of multi-
drug resistant (MDR) TB is the highest of all American countries and continues to increase
[2,3].
Early detection, diagnosis and notification of TB is a global priority for TB control efforts
and is emphasized in the World Health Organization (WHO) End-TB Strategy [4, 5]. In 2015,
only 57% of TB cases were estimated to have been diagnosed and notified globally [1]. Low
case detection and delays in treatment initiation contribute to increased household and com-
munity transmission of TB, severity of individual disease, and risk of adverse treatment out-
comes [6].
Globally, TB is recognized as a socially stratified disease that clusters among disadvantaged
groups. This has recently been confirmed in the setting of the current research [7,8]. An ineq-
uitable distribution of low income, food insecurity, poor housing, unhealthy environmental
conditions, and other social determinants exacerbate poor TB control in areas of low socio-
economic position [9]. In order to meet the ambitious targets set out in the End-TB Strategy
and ensure the prompt diagnosis and treatment of often vulnerable individuals, it is important
to understand the relationships between social determinants and TB diagnostic delay [10], and
how interventions may address these social determinants [11].
The reasons and risk factors for diagnostic delay have been investigated in many parts of
the world and vary considerably according to the context [12–18]. Several studies have exam-
ined diagnostic delay, but none have used comparative analyses of qualitative data collected
from persons diagnosed with TB (PDTB), family members, and health personnel working in
the NTP [19–21].
The objective of this study was to identify and characterize the social determinants that con-
tribute to diagnostic delay among PDTB living in Lima and Callao, Peru. We focused on the
perspectives of PDTB, their family members, and health personnel in order to gain an individ-
ual, community, and health-system level understanding of this phenomenon.
Methods
Setting
From May to October 2015, this study was conducted in 25 public health facilities throughout
19 districts of Lima and Callao, Peru. The estimated population of Lima and Callao is 9.8 mil-
lion people living in 50 districts, defined by having a mayor and municipality. In order to select
Social determinants underlying TB diagnostic delay
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the districts for this research, we met with regional TB coordinators in 7 health management
network offices to identify geographically distinct districts with the highest respective TB bur-
dens for their network. Districts varied from desert shantytowns to dense, historical city neigh-
bourhoods. All public health facilities had a designated TB treatment program with at least one
nurse technician devoted exclusively to working with PDTB.
Participants
Inclusion criteria were PDTB (n = 105) aged at least 18 years old, who were currently taking
treatment for their first episode of pulmonary TB in a public health facility regulated by the
NTP, whose NTP treatment card indicated that they had had a sputum smear microscopy pos-
itive result. In Peru, sputum smear microscopy is the only widely-used rapid laboratory test.
Culture and molecular testing are largely restricted to drug-susceptibility testing after TB has
been diagnosed. We included people with drug-sensitive and drug-resistant TB. Exclusion cri-
teria were inability or unwillingness to give written, informed consent, and history of past TB
disease.
PDTB were selected to participate by convenience sampling whereby we approached indi-
viduals taking treatment for TB at selected public health facilities who happened to be present
at the time of our visit. Approximately 10% of PDTB declined to participate in our study. All
recruited PDTB gave written informed consent to be interviewed and were asked to agree to a
home visit. Family members interviewed (n = 63) were currently living in the same household
or city district as the PDTB. Recruited family members were also selected by convenience sam-
pling whereby we approached them at the time of our home visits. Six focus groups were held,
each with 5–8 health personnel. These health personnel included doctors, nurses, nutritionists,
lab technicians, social workers, nursing technicians, and/or psychologists who currently and/
or previously worked with PDTB in the study districts. Family members and health personnel
gave verbal consent to participate.
Data collection
Healthcare experiences and community perceptions of TB disease were explored with current
PDTB, their family members, and health personnel who currently and/or previously practiced
in the NTP. Two methods were used: (1) semi-structured interviews; and (2) focus group
discussions.
(1) Semi-structured interviews. All PDTB were interviewed using a semi-structured
interview guide developed from a prior WHO survey of diagnostic and treatment delay [12].
This document was reviewed and edited by three Peruvian medical professionals with more
than twenty years of experience with TB in-country. Thereafter, it was piloted during 2 pilot
interviews with PDTB and modified based on their responses. The pilot interviews were only
used for refining the interview guide, were not recorded, and are not further reported here.
Data from pilot interviews are not included in the main study. The main study interviews
lasted 30 minutes to 1 hour, over 1 or 2 meeting occasions, and explored the following themes:
socio-demographics; household environment and family composition; migration history; past
medical history; history of patient’s illness including symptoms; health-care seeking behav-
iours; and socio-economic consequences of TB. Medical charts were also reviewed for history
of past TB disease and other comorbidities. Interviews with family members lasted 5 to 30
minutes and were conducted either in the public health facility or the family member’s home,
depending on their preference. These interviews focused on community perceptions of TB dis-
ease, its causes and social consequences, common health seeking behaviours and interactions
people had with the public health system. All interviews were conducted in Spanish and
Social determinants underlying TB diagnostic delay
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digitally recorded. These recordings were then transcribed for analysis except in three cases
when recording was declined. Detailed notes were taken in these cases.
(2) Focus groups. Focus groups with health personnel lasted 40 to 90 minutes and ques-
tioned community perceptions of TB disease and common health seeking behaviours. Rela-
tionships and attitudes between health personnel, PDTB, and the NTP were discussed.
Participants were encouraged to provide what they thought were the general opinions and
behaviours of the populations in which they worked. The discussions were freeform, such that
participants could respond to one another’s comments and build on emerging themes. Inter-
view guides for PDTB, family members, and health personnel are shown in the online
supplement.
Analysis. Diagnostic delay was defined as the number of days between symptom onset and
the first smear positive TB diagnostic sample recorded by public health facilities regulated
under the NTP. PDTB first described their symptoms of TB and then we specifically asked
them if they had experienced cough, fever, weight loss, and/or hemoptysis. Symptoms
described by PDTB included cough, fever, weight loss, hemoptysis, fatigue, and night sweats.
We used the date PDTB self-reported their first symptom related to TB as the date of symptom
onset. The number of days of diagnostic delay was then back-calculated using this date.
All spoken words from the interviews and focus groups were analysed using a grounded
theory approach. Interviews and focus groups were reviewed to identify emerging themes and
concepts. Using the software Atlas.ti 7 (Scientific Software Development GmbH, Berlin, Ger-
many) a list of conceptual codes was then created to organize and group information provided
by participants. A fully coded analysis of all transcripts was completed and used to create a
conceptual framework of factors contributing to diagnostic delay. Translation of representa-
tive quotes from Spanish to English was done after analysis. Descriptive statistics were calcu-
lated using Excel 2013 (Microsoft Office).
Ethics statement. The study received ethical approval from the Institutional Committee of
Research Ethics at the Peruvian National Institute of Health and the Internal Review Board of
Health Sciences and Behavioral Sciences at the University of Michigan, USA.
Results
Demographic characteristics of all PDTB are shown in Table 1. The median age was 28 and
38% were female. Table 2 shows characteristics of the family members interviewed. The
median age was 46 and 87% were female. Table 3 outlines characteristics of the focus groups,
for whom the median duration working with PDTB was five years.
Diagnostic delay
The median diagnostic delay was 57 days (interquartile range (IQR): 28–126). Interview and
focus group data were organized conceptually into five categories that directly or indirectly
contributed to diagnostic delay. Categories are illustrated in Fig 1 and are presented below
with direct quotes from PDTB, family members, and health personnel. Table 4 shows descrip-
tions of codes used to create the conceptual framework.
A. Material resources, time availability, and available social support. The median indi-
vidual income of all PDTB was US $218 per month (IQR: 116–349). It was universally agreed
that indirect and direct costs associated with healthcare visits often contributed to patients’
delay in seeking professional care.
“[I waited] because of work. . .there was no time. I returned in the night from my job, around
8:30 pm and at this time the health posts are not open.”
Social determinants underlying TB diagnostic delay
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(Male Patient, Interview)
“I didn’t want to bother my children. I felt so alone. I didn’t want to leave [my house]. My hus-
band treated me bad and I wanted to die. . .I didn’t have money [to go to the doctor].”
(Female Patient, Interview)
For those PDTB who did have available social support, preoccupation by family and friends
was noted as a key motivation for accessing health facilities.
“In the month of April I started to feel a little sick and I was coughing frequently and my mom
got worried and made me go to the hospital for an appointment.”
Table 1. Demographic characteristics of all persons diagnosed with TB.
Variable Units Persons diagnosed with TB (n = 105)
General Age median (IQR) 28 (22–49)
Female sex n (%) 40 (38)
Monthly personal income median $US (IQR) 218 (116–349)
City districts San Juan de Lurigancho n (%) 18 (17)
El Augustino n (%) 7 (7)
La Victoria n (%) 14 (13)
Santa Anita n (%) 6 (6)
ATE n (%) 2 (2)
Lurin n (%) 3 (3)
Villa Maria del Triunfo n (%) 3 (3)
Villa El Salvador n (%) 3 (3)
San Juan de Miraflores n (%) 4 (4)
Bellavista n (%) 3 (3)
Rimac n (%) 5 (5)
San Martin de Porres n (%) 14 (13)
Independencia n (%) 3 (3)
Los Olivos n (%) 6 (6)
Callao n (%) 3 (3)
Ventanilla n (%) 4 (4)
Mi Peru n (%) 1 (1)
Carabayllo n (%) 3 (3)
Comas n (%) 3 (3)
https://doi.org/10.1371/journal.pone.0185018.t001
Table 2. Demographic characteristics of all family members interviewed.
Variable Units Family member (n = 63)
General Age median (IQR) 46 (39–54)
Female sex n (%) 55 (87)
Previously had TB n (%) 3 (5)
Relation to person diagnosed with TB Parent n (%) 31 (49)
Sibling n (%) 5 (8)
Child n (%) 6 (10)
Spouse n (%) 10 (16)
Other n (%) 11 (17)
https://doi.org/10.1371/journal.pone.0185018.t002
Social determinants underlying TB diagnostic delay
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(Female Patient, Interview)
Fear associated with a possible diagnosis was frequently mentioned as another barrier to
seeking professional medical attention.
“Some people are afraid of what they [the doctors] will say. They have TB and they [the
patients] think that the people are going to treat them poorly.”
(Family Member, Interview)
Health personnel also mentioned that fear of being sick extended to fear of job loss. As dis-
cussed in every focus group, PDTB often struggled to maintain sufficient household income in
resource-constrained settings.
Table 3. Demographic characteristics of focus groups.
Variable Units Focus Group Discussion (n = 6)
General Total health professionals n (%) 35 (100)
Number of health professionals per focus group median (IQR) 5.5 (5–6)
Years working in TB median (IQR) 5 (3–14.5)
Occupations Physician n (%) 11 (31)
Technical nurse n (%) 7 (20)
Nurse n (%) 12 (34)
Nutritionist n (%) 2 (6)
Laboratory technician n (%) 1 (3)
Psychologist n (%) 1 (3)
Social worker n (%) 1 (3)
The age of health personnel was not recorded for confidentiality purposes. Note: IQR indicates interquartile range; TB indicates tuberculosis.
https://doi.org/10.1371/journal.pone.0185018.t003
Fig 1. Conceptual framework of factors contributing to diagnostic delay. See the results section of the manuscript for explanations
of categories A, B, C, D, and E.
https://doi.org/10.1371/journal.pone.0185018.g001
Social determinants underlying TB diagnostic delay
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Table 4. Codes used to create the conceptual framework.
Factors contributing to
diagnostic delay
Conceptual codes: PDTB Conceptual codes: family
members
Conceptual codes: health personnel
A. Material resources and social
support available
Initial reactions to symptoms Reasons for high TB
prevalence
Reasons for high TB prevalence
Knowledge of TB prior to diagnosis Groups at greater risk of
contracting TB
Groups at greater risk of contracting TB
Knowledge of TB transmission Common community
knowledge of TB
Common community knowledge of TB
Knowledge of causes of TB Initial reactions to TB diagnosis
Other health beliefs related to TB
mentioned
Generalized beliefs and behaviors of PDTB
Reasons why individuals wait to seek
care at public health posts
Initial reactions to TB diagnosis
B. Previous knowledge and
experience with illness
Knowledge of TB transmission Reasons for high TB
prevalence
Reasons for high TB prevalence
Knowledge of causes of TB Groups at greater risk of
contracting TB
Common community knowledge of TB
Other health beliefs related to TB
mentioned
Common community
knowledge of TB
Initial reactions to TB diagnosis
Reasons why individuals wait to seek
care at public health posts
Initial reactions to TB diagnosis Initial reactions to TB diagnosis
C. Threshold of symptom severity Reasons for seeking professional
medical attention
Health seeking behaviors Average time PDTB wait before they seek
attention at a public health facility
Progression of symptoms to diagnosis Health seeking behaviors
following hemoptysis
D. Health seeking behaviors Health seeking behaviors Health seeking behaviors Practices of private clinics
Reasons for seeking attention from a
professional health facility
Motivations for self-
medication
Motivations for self-medication
Description of first experience with a
professional health facility
Time waiting at first professional health
facility
Personal treatment received from first
professional health facility
E. Community and health system
reactions to TB disease
Personal treatment received from first
professional health facility
Community opinions of TB Attitudes of health personnel working in the
National Tuberculosis Program
Concealment of TB diagnosis Community treatment of
PDTB
Interactions between health personnel and
PDTB in the public health post
Changes in work or studies due to TB
diagnosis
Consequences of TB diagnosis
Embarrassment due to TB diagnosis Political inhibitions to TB control
Changes in familial interactions due to
TB diagnosis
Reasons for high TB prevalence
Changes in social interactions due to
TB diagnosis
Groups at greater risk of contracting TB
Note TB indicates tuberculosis; PDTB indicates persons diagnosed with TB.
https://doi.org/10.1371/journal.pone.0185018.t004
Social determinants underlying TB diagnostic delay
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“For example, in [their neighbourhoods], they live in completely overcrowded conditions not
because they want to, but because their economic situation obligates them to be there.”
(Health Care Worker, Focus Group)
B. Previous knowledge and experience with illness. Prior to diagnosis, almost all PDTB
had, at least, heard of the existence of a disease called TB in their communities. PDTB generally
associated TB with poor nutrition and low immune defences due to excess of work, stress, or a
“disordered” life of drug, alcohol, and cigarette use for example.
“I thought TB was for people who did not eat, for the vagabonds that didn’t look after their
things.”
(Male Patient, Interview)
When PDTB first started experiencing typical TB symptoms, it was very often attributed to
a common virus.
“I sincerely thought it was something that would pass because I never would have thought to
get this disease. I thought it was a cough.. . .”
(Male Patient, Interview)
Family members held similar ideas of TB as a nutritional disease that predominantly affects
those with weak immune systems.
“Weak people [are at major risk]. For example, a person dedicated to studying in the univer-
sity. He, [my son] got good grades in school and he neglected food. . .and the bus dropped him
very far from the university. All this physical activity and responsibility killed my son.”
(Family Member, Interview)
Community knowledge of TB treatment was variable; some family members reporting
widespread knowledge of Peru’s NTP and others none.
“I guess that, if there was a percentage, 70% don’t know [about treatment for TB].”
(Family Member, Interview)
“The whole world knows that if you have TB you leave your sputum for free and they give you
your medicine for free.”
(Family Member, Interview)
Health personnel agreed that upon seeing PDTB for the first time, many have some aware-
ness of the disease, although few know details such as treatment length or the quantity or type
of treatment medications.
“When they come for the first time, they tell us it’s a contagious disease. And they come worried
because maybe they have infected someone.. . . So they have some knowledge, but what they
don’t know is how long treatment lasts. They only know it is contagious.”
(Health Care Worker, Focus Group)
Social determinants underlying TB diagnostic delay
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C. Threshold of symptom severity. Eventually, every PDTB’s health deteriorated to a
point where they had to seek medical attention. Although each PDTB held their own individ-
ual threshold, most went to see a physician after ill health prevented them from conducting
daily activities including working; was noted as extremely abnormal; or persisted for an unusu-
ally long time.
“I lost weight because I was sweating a lot. I felt really cold and I lost 15 kilos in two weeks and
this was very worrisome.”
(Female Patient, Interview)
“The cough made my chest hurt. I couldn’t take it. . .I started to feel pain behind in my back. I
had fever and my body hurt. My fever was too high.”
(Male Patient, Interview)
“It came to the extreme. . .I threw up blood from my nose, my mouth. . .and I went to the
hospital.”
(Male Patient, Interview)
Half of family members agreed that most people do not seek medical attention until a rela-
tively high threshold of symptoms is passed, such as when people begin to cough blood.
“Here in Peru people wait to see if it will pass normally and when they fall really sick that is
when they go [to the doctor].”
(Family member, Interview)
“[Coughing blood] is something else. Then they go to the hospital. Definitely the hospital.”
(Family Member, Interview)
In focus groups, health personnel noted that most PDTB normally waited weeks, if not
months, to seek treatment, after symptoms appeared.
“Some delay, some wait, coughing, and they come when it doesn’t pass with any pills and they
start to vomit blood. . ..”
(Health Care Worker, Focus Group)
D. Health seeking behaviours. PDTB first health seeking behaviours were largely deter-
mined by influential factors described in the three previous sections. The most common initial
behaviour, was to self-medicate with pills including antibiotics such as amoxicillin and levo-
floxacin, cough syrups, injections bought without medical prescription from pharmacies or
natural medicines.
“It was for a throat infection. Every day I took different pills because I was going to different
pharmacies and they told me I was sick in the throat.. . . I thought it would pass in the night
and the next day it came back.. . . At this time I didn’t have health insurance and I didn’t have
time [to go to the doctor].”
(Female Patient, Interview)
Social determinants underlying TB diagnostic delay
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Unlike public health facilities, most pharmacies stay open until late in the night, after work-
ing hours. They are the most accessible facilities to receive healthcare, especially for working
people who leave their homes early in the morning and return in the night. Medical advice
provided by the individuals working there is also free and rapid and does not require proof of
health insurance.
“They always go to the pharmacy and they say this or that and they get a diagnosis and a pill.
It’s faster. . .sometimes there is no time to go to the health post. . .Here you have to work and if
you don’t, you don’t survive.”
(Family Member, Interview)
However, as noted in focus groups, the advice given in pharmacies very rarely, if ever, is
given by professionally trailed health practitioners. Individuals cannot receive the correct tests
or treatment for TB so attention provided by pharmacies may increase diagnostic delay in
these communities.
“In [the pharmacy] it is not the pharmacist that sees you, but rather the technical assistant,
but not even the pharmacist is authorized to prescribe [TB] medications.”
(Health Care Worker, Focus Group)
“I have seen [the pharmacy] give levofloxacin for up to three days. Imagine that.”
(Health Care Worker, Focus Group)
Using natural medicine was another common health seeking behaviour before seeking care
from a physician.
“[I took] coca caramels, water with salt, some herbs, but nothing passed. . .Pills are a lot of
chemicals and they told me that first you start with natural things and then take drugs. . .”
(Female Patient, Interview)
The remaining PDTB who did not first self-medicate or take natural medicine used public
health facilities, public hospitals, employer insured health facilities, or private clinics as their
first health seeking behaviour. Their decision to pay out-of-pocket expenses for private care or
use the state-insured or employer-insured health system largely depended on the person’s
amount of available time and money and where they held the greatest trust. Long wait times
were frequently noted as an obstacle for using the insured systems. Health personnel admitted
that many individuals resorted to use of these facilities only if it was the last available option
for them.
“People have the perception that if they go to a private doctor they are going to receive better
attention. . .”
(Health Care Worker, Focus Group)
“The majority come with one month of symptoms—they thought it was something normal or
they went to the pharmacies or did what their mother, sister, grandmother told them to do.
When the symptoms persist they go to a private professional and since he doesn’t have much
experience he says upper respiratory infection. And then they continue hurting and then finally
go to the public health post when a lot of time has passed.”
(Health Care Worker, Focus Group)
Social determinants underlying TB diagnostic delay
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Although all PDTB eventually did seek professional medical attention, most had to visit two
or more professional health facilities to receive a diagnosis of TB and enter the NTP to receive
free treatment.
“I went to the [private] doctor and he gave me shots, cough syrups, and it didn’t pass. The fever
went, the body aches went, but the cough didn’t. . .. Again, I went to the [private] doctor and
he gave me another cough syrup and a pill, an antibiotic. . .Nothing passed. . .A woman [in my
neighbourhood] told me to go to a public health clinic close by so I could leave my sputum sam-
ple because the cough is dangerous and maybe I have TB. . .”
(Male Patient, Interview)
E. Community and health system response to TB disease. After diagnosis, the great
majority of PDTB reported that they faced discrimination within their communities. Most
admitted hiding their diagnosis from friends, work colleagues, and even some family mem-
bers, attempting to avoid stigma and its subsequent socio-economic consequences.
“I don’t want them to be scared.. . . I hide [my diagnosis] for work because if I didn’t, I
wouldn’t be working. . .”
(Male Patient, Interview)
“Sometimes people think that TB is for people who have bad lives, but in my case, I don’t have
a bad life because I don’t drink, I don’t smoke, I don’t go to parties. . .”
(Female Patient, Interview)
“If you have TB. . .you feel like a source of infection and the people are going to, they are going
to reject you. . .”
(Male Patient, Interview)
Family members agreed that discrimination within communities often stemmed from a
fear of disease contagion.
“They are scared, they say it’s contagious and they don’t want to go close to [the TB patient].
They isolate them.”
(Family Member, Interview)
Health personnel admitted, in concordance with testimonials from PDTB, that discrimina-
tion within health facilities was strong and common.
“I had a patient and I asked him, why did you abandon treatment? He said the nurse left him
the pills on the table and then everyone disappeared, everyone left running.. . . The patient
said: why am I going to come here if they treat me bad, if I feel bad? A TB patient has low self-
esteem, and with the treatment we give him it gets worse. . ..”
(Health Care Worker, Focus Group).
Health personnel in focus group discussions often noted that many of their colleagues did
not want to work in the NTP for fear of contagion.
Social determinants underlying TB diagnostic delay
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“There are some who consider it a punishment and look for a way to get out of working in the
TB Program.”
(Health Care Worker, Focus Group)
As noted in focus groups, although the Peruvian NTP has established treatment guidelines,
many of them are not strictly followed due to a lack of human resources. Similarly, NTP poli-
cies state that all PDTB should receive support from several different health professionals
including psychologists throughout treatment, but public health facilities often cannot com-
plete the array of specialty appointments the NTP aims to provide.
“This is the route: nurse, doctor, psychologist, nutritionist, social worker, and obstetrician if you
are a woman. This is the route, but it’s not really like this. We don’t follow it because there are
not complete teams in the health posts, and in those that are they can’t meet the demand. . .”
(Health Care Work, Focus Group)
The lack of political will to support a stronger multi-disciplinary effort against TB was also
described during focus groups as a major barrier to finding disease and subsequently decreas-
ing diagnostic delay in high burden areas. With limited health staff, public health facilities are
often left with no resources to run social and/or educational programs that might reduce
stigma, disseminate information into communities and/or encourage prospective patients to
seek care at public health facilities.
“There is a multi-sectorial strategic plan and it involves the ministry [of health], but it is not
taken up. They do not give it the importance it should be given.. . . [It] is a plan that should
include all of the ministries, but it is not being applied. . .”
(Health Care Worker, Focus Group)
“We have technical guidelines, which obligate that we focus on integral treatment, and they
also include an educational part and require private and public institutions to make work
plans [for PDTB] that they are still not executing. We should work so that people. . .have more
information [about TB] and break stigmas that TB is only for poor people, homeless people, for
ignorant people. . .We have to [advertise our program] as free. Some people don’t come because
of the cost. They are scared of [losing] money.”
(Health Care Worker, Focus Group)
Discussion
Prompt diagnosis and treatment of TB is important for reducing morbidity, mortality, and
preventing TB transmission [22,23]. Our results show that PDTB generally experienced symp-
toms associated with TB for approximately two months before receiving a diagnosis. These sig-
nificant diagnostic delays were largely influenced by five defining areas: (A) material
resources, time availability, and available social support; (B) knowledge and previous experi-
ence with illness; (C) threshold of symptom severity; (D) health seeking behaviours; and (E)
community and health system responses to TB disease. Understanding these five areas may
help strengthen health systems seeking to improve case-finding and health promotion strate-
gies. Consequently, this may reduce detrimental diagnostic delays [24–27] that increase com-
munity transmission, a major contributor to high TB incidence rates [28].
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During focus groups and interviews, many individuals associated TB with poor nutrition
and high consumption of alcohol and/or illegal drugs, as reported previously in Peru [29].
This belief created a stereotypical profile of PDTB within communities and may subsequently
contribute to diagnostic delays for individuals who have symptoms of TB if they do not suspect
that they have TB because they do not fit this stereotype. Although only a small proportion of
PDTB in our sample reported extensive use of alcohol and/or illegal substances, our data is
subject to recall and social desirability biases. Despite this, our results suggest that the associa-
tion of TB with substance abuse was exaggerated within communities and by health personnel
in our setting. This exaggeration may contribute to the stigma felt by PDTB and by extension,
the reported fear that delayed some individuals from seeking healthcare. Many PDTB associ-
ated their symptoms to a common virus and as in other studies, lack of knowledge of TB was
associated with diagnostic delay [30,31]. Our findings suggest that grade of knowledge influ-
ences threshold of symptom severity and health seeking behaviours by PDTB, as shown in
Fig 1.
As reported in other studies, many PDTB prioritized working over seeking professional
medical attention when they began to feel ill [31,32]. The income of most participants was sim-
ilar to Peru’s minimum monthly salary of US $215 and although TB diagnostic tests are free of
direct charges in Peru, many PDTB reported anticipated costs associated with visiting a physi-
cian as a reason for diagnostic delay [33]. Furthermore, wait times were perceived as extremely
long when using public or employer-insured health facilities, as was quantified in another
study in Peru [31] and described in other settings [15]. If PDTB had the economic resources to
do so, many preferred to first visit private clinics, a preference previously reported by other
studies [32,34]. We suggest that the Peruvian NTP collaborates with private clinics to promote
consideration of TB as a possible diagnosis amongst their patients and additionally, encourage
all PDTB to seek free treatment in public and employer-insured health facilities as quickly as
possible.
Overwhelmingly, PDTB in this study declared that they had little trust in the public health
system. Most PDTB admitted to visiting public health facilities only when they continued to
experience symptoms and their other options for available healthcare decreased. As in other
studies, when economically insecure, time-pressured individuals enter a resource-constrained
public health system, we found that most PDTB experienced stigma [35–37]. The shared
demand for material resources and social and occupational support amongst actors in the
health system may maintain community knowledge gaps, weaken trust and entrench already
established stigma. This may contribute to diagnostic delay through the relationships shown
between areas (A), (B), and (E) of Fig 1. Studies from Malawi, Nepal, and Ghana have shown
stigma produced through similar relationships between PDTB and health personnel
[15,38,39].
Statements by PDTB, family members, and health personnel suggested that strong social
support acted as a catalyst for seeking care in professional health facilities. This supports simi-
lar qualitative results from the Philippines which describe the importance of accompaniment
in initiating care seeking behaviour [32]. Additionally, a study from Uganda found that indi-
viduals most often seek advice from their immediate social network when first experiencing
symptoms of TB [40]. In our study, a lack of social support may then contribute to diagnostic
delay through increasing the threshold of symptom severity required before initiating health
seeking behaviours. Consequentially, these health seeking behaviours may lead to further delay
based on the time to diagnosis in public health facilities.
Self-medication was frequently reported when PDTB first began to experience TB symp-
toms. Self-medicating with antibiotics and other medications bought from pharmacies in
areas including Tanzania, has been shown to contribute to diagnostic delay and may also
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contribute to the generation of antibiotic resistance [41–44]. The high proportion of PDTB
attending pharmacies before visiting professional health facilities identifies a location that
future public health campaigns could target in their TB case-finding initiatives. Globally, few
pharmacies advise their customers to seek professional medical attention [34,45,46]. We sug-
gest that the Peruvian NTP collaborate with pharmacies to train their employees to identify
customers seeking medications to relieve symptoms of possible TB. We encourage the NTP to
offer these pharmacies information leaflets and sample containers that customers, or the indi-
viduals for whom they represent, could deliver to the closest public health post for free TB test-
ing. This working relationship between the NTP and pharmacies could be established through
recovering PDTB, who may be recruited to help find TB in pharmacies operating in the neigh-
bourhoods in which they live.
This study has several limitations. Reporting and recall biases may have occurred because
participants provided responses retrospectively. We aimed to reduce this by questioning and
reconfirming participants’ narratives. The study is also subject to selection bias because we
used convenience sampling to recruit PDTB and their family members. However, the study
took place in multiple diverse health centres and approximately 10% of patients declined to
participate, so any possible selection biases could not have explained our findings. Addition-
ally, we only studied diagnostic delay in adults, and did not include children and adolescents
who are high risk groups for TB. The study design inevitably excluded people with undiag-
nosed TB because they were either: (1) people with never-to-be-diagnosed prevalent TB that
can only be diagnosed by door-to-door prevalence surveys; or (2) chronic and/or paucisymp-
tomatic TB that had not yet been diagnosed. Another limitation concerns our definition of
diagnostic delay as the number of days between symptom onset and the first smear positive TB
diagnostic sample recorded by public health facilities regulated by the NTP. This definition
may neglect some earlier sputum samples that could have been positive for TB if more sensi-
tive tests like sputum culture had been used. The precise number and characteristics of PDTB
who declined to participate were not recorded; however, this affected approximately 10% of
PDTB and so it is unlikely to have caused important bias. This issue has prompted current
ongoing research interviewing PDTB who decline research participation, to better understand
how their characteristics may differ from research participants.
The first author of this manuscript was the only person who fully coded transcripts for qual-
itative data analysis. In order to ensure high-validity of research results, we triangulated
sources and methods by conducting interviews with patients and their family members and
focus groups with health personnel. All data were analysed using a grounded theory approach,
whereby the person carrying out analysis remained aware of her own preconceived ideas and
used “bracketing” to prevent these ideas from influencing her examination of accounts from
participants [47]. Data were collected past the point of saturation, after no new ideas emerged
from interviews or focus groups.
Future research might quantify subsequent health system delay following TB diagnosis.
This is the time between official diagnoses in the NTP and start of treatment. Although other
studies have noted this delay to be comparatively minor, further research may shed light on
additional opportunities to strengthen Peruvian NTP activities and help pinpoint other needed
resources [22]. Future research should also evaluate social and/or economic interventions to
reduce diagnostic delay with interventions that may be informed by our findings.
Conclusions
Overall, this study demonstrated that diagnostic delays are frequent, and associated with
important underlying social determinants. PDTB, their family members and health personnel
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all stated that when individuals reach a threshold of symptom severity, they address their
health with the least time-consuming, most economically feasible and well-known healthcare
option available to them. Our findings suggest that in Peru and other resource-constrained set-
tings the development and/or improvement of policies that address and help reduce diagnostic
delays are urgently needed to reduce community transmission, morbidity, and mortality.
Case-finding initiatives should target locations that are a first point of contact for possible
PDTB, shown to be pharmacies in our research. More and improved material and human
resources are required in health clinics and private sector health facilities to implement these
strategies, reduce TB associated stigma, and address the multifaceted social determinants of
TB.
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